Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Xingmeng Pharmaceutical is a China-based pharmaceutical company focused on the development, manufacturing, and commercialization of high-quality generic and innovative drugs, with a particular emphasis on anti-infectives and liver diseases. The company operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to produce a variety of dosage forms, including tablets and capsules. One of its key commercial products is Entecavir, a potent antiviral used for the treatment of chronic Hepatitis B infection. Hunan Xingmeng Pharmaceutical aims to provide affordable and effective therapeutic options to patients within the Chinese domestic market and potentially international markets through its integrated R&D and production capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Xingmeng Pharmaceutical.